Q4 revenues NOK 998m, -1/-3% vs ARCe/Cons.EBIT NOK 103m, +2/-2% vs ARCe/Cons.EPS NOK 0.69/sh, -6/-10% vs ARCe/Cons.FTEs: 2,367 (ARCe: 2,324)Billing rate 77.8% (ARCe: 78.1%)Expect slightly negative estimate revisionsSmall negative share price reaction warranted
